Central regions | Finance, business | Technology & innovation

HIV drug development under way, gets Skolkovo support

30 May '16
Viriom, a biomedical developer and asset of the ChemRar High Tech Center in Khimki outside Moscow, has been working on Russia’s first HIV solution which is expected to go beyond import substitution—an across-the-board goal the Russians have been pursuing in many sectors since the current crisis and western sanctions began—and offer “high potential for international commercialization.”

The new drug candidate’s safety, high efficacy and tolerance are said to have been proven during five rounds of phases 1 and 2 clinical trial testing. Phase 3 of clinical trials is currently under way in 18 AIDS prevention centers across Russia.

The Skolkovo Foundation, which is managing Russia’s most widely touted innovation hub just outside Moscow, earlier this year approved a new $2.2m grant for the next stage of the effort.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
20 Jul '17 | Technology & innovation
19 Jul '17 | Transport, logistics
17 Jul '17 | Finance, business | Technology & innovation
14 Jul '17 | Materials, extraction | Technology & innovation
6 Jul '17 | Finance, business | Technology & innovation
 

Feature stories

20 Jun '17
In regions most of European Russians will hardly ever...
17 May '17
Russian biologists and biophysicists are said to have...
21 Apr '17
Search (News archive - 21116)
Advertising
RB_Partners_Venture_Report2016
Advertising
Why Russians do not smile
Advertising
Nano & Giga Symposium
Advertising
UNN

Latest News

20 Jul '17
Russian scientists are said to have successfully...
19 Jul '17
Scientists at MISiS, a top Moscow-based technology...
18 Jul '17
Scientists in Tomsk, in Siberia, have pioneered the...

Most read stories from last week

20 Jul '17
Russian scientists are said to have successfully...
18 Jul '17
Scientists in Tomsk, in Siberia, have pioneered the...
19 Jul '17
Scientists at MISiS, a top Moscow-based technology...